List of works - Jonathan Clapp

Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.

scientific article

Baseline characteristics of participants in the randomized national lung screening trial

scientific article

Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).

scientific article

Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?

scientific article

Cumulative incidence of false-positive results in repeated, multimodal cancer screening

scientific article

Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.

scientific article published in April 2010

Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

scientific article

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

scientific article published on 31 March 2017

Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).

scientific article

Mortality results from a randomized prostate-cancer screening trial

scientific article

Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance).

scientific article published on 20 February 2017

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial

scientific article published on March 2005

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

scientific article published on 6 January 2012

Reduced lung-cancer mortality with low-dose computed tomographic screening

scientific article (publication date: 4 August 2011)

The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates

scientific article published on 17 February 2018

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)

scientific article

List of works by Jonathan Clapp

Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901.

Baseline characteristics of participants in the randomized national lung screening trial

Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).

Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?

Cumulative incidence of false-positive results in repeated, multimodal cancer screening

Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.

Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.

Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).

Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).

Mortality results from a randomized prostate-cancer screening trial

Personality, coping, and social support as predictors of long-term quality-of-life trajectories in older breast cancer survivors: CALGB protocol 369901 (Alliance).

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

Reduced lung-cancer mortality with low-dose computed tomographic screening

The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)